CHICAGO, July 11, 2024 /PRNewswire/ — The global GLP-1 analogues market is poised for substantial growth, projected to expand from USD 47.4 billion in 2024 to USD 471.1 billion by 2032, at a robust CAGR of 33.2%. Key drivers include the drugs’ efficacy in managing diabetes and obesity,…